Rua Bioscience Limited (NZE:RUA)

Rua Bioscience Statistics

Total Valuation

Rua Bioscience has a market cap or net worth of NZD 13.83 million. The enterprise value is 14.32 million.

Market Cap	13.83M
Enterprise Value	14.32M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Rua Bioscience has 238.45 million shares outstanding. The number of shares has increased by 9.17% in one year.

Current Share Class	238.45M
Shares Outstanding	238.45M
Shares Change (YoY)	+9.17%
Shares Change (QoQ)	+2.88%
Owned by Insiders (%)	22.75%
Owned by Institutions (%)	n/a
Float	163.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.28
PB Ratio	2.83
P/TBV Ratio	5.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.15
EV / Sales	7.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.26

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.15.

Current Ratio	1.25
Quick Ratio	0.32
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.27
Interest Coverage	-20.37

Financial Efficiency

Return on equity (ROE) is -59.29% and return on invested capital (ROIC) is -32.51%.

Return on Equity (ROE)	-59.29%
Return on Assets (ROA)	-28.09%
Return on Invested Capital (ROIC)	-32.51%
Return on Capital Employed (ROCE)	-66.18%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.26
Inventory Turnover	1.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.15% in the last 52 weeks. The beta is 0.24, so Rua Bioscience's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	+67.15%
50-Day Moving Average	0.05
200-Day Moving Average	0.03
Relative Strength Index (RSI)	69.43
Average Volume (20 Days)	146,939

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rua Bioscience had revenue of NZD 1.90 million and -3.46 million in losses. Loss per share was -0.02.

Revenue	1.90M
Gross Profit	923,232
Operating Income	-3.26M
Pretax Income	-3.46M
Net Income	-3.46M
EBITDA	-2.92M
EBIT	-3.26M
Loss Per Share	-0.02

Balance Sheet

The company has 241,421 in cash and 735,598 in debt, giving a net cash position of -494,177 or -0.00 per share.

Cash & Cash Equivalents	241,421
Total Debt	735,598
Net Cash	-494,177
Net Cash Per Share	-0.00
Equity (Book Value)	4.89M
Book Value Per Share	0.02
Working Capital	452,527

Cash Flow

In the last 12 months, operating cash flow was -2.72 million and capital expenditures -3,430, giving a free cash flow of -2.72 million.

Operating Cash Flow	-2.72M
Capital Expenditures	-3,430
Free Cash Flow	-2.72M
FCF Per Share	-0.01

Margins

Gross margin is 48.60%, with operating and profit margins of -171.68% and -181.90%.

Gross Margin	48.60%
Operating Margin	-171.68%
Pretax Margin	-181.90%
Profit Margin	-181.90%
EBITDA Margin	-153.85%
EBIT Margin	-171.68%
FCF Margin	n/a

Dividends & Yields

Rua Bioscience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.17%
Shareholder Yield	n/a
Earnings Yield	-24.99%
FCF Yield	-19.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rua Bioscience has an Altman Z-Score of -7.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.55
Piotroski F-Score	3